Cerebral Cortex
September 6, 2018
Gregory M. James, Gregor Gryglewski, Thomas Vanicek et al.
16 citations
The cerebral cortex can be divided into distinct areas based on the density of proteins involved in the serotonin system. Using positron emission tomography in healthy participants, the study quantified serotonin 1A receptors (n = 30), 5-HT2A receptors (n = 22), the serotonin-degrading enzyme monoamine oxidase A (n = 32), and the serotonin transporter (n = 24). Clustering analysis identified five optimal clusters of cortical regions defined by these molecular profiles. These clusters explained the effects of psychotropic drugs acting on serotonin, such as antidepressants and psychedelics, suggesting the method is useful for integrating multimodal imaging data in neuropharmacology and psychiatry.
Wiener klinische Wochenschrift
March 1, 2025
Pia Baldinger-Melich, Marie Spies, Ina Bozic et al.
5 citations
Modern electroconvulsive therapy (ECT) and nasal esketamine have significantly improved treatment for treatment-resistant depression (TRD), defined as non-response to at least two adequate antidepressant courses. This literature review presents evidence on efficacy and safety, comparing advantages, disadvantages, and response rates. Both treatments are highly effective for TRD. The choice between esketamine nasal spray and ECT should consider contraindications, age, severity, psychotic symptoms, patient preference, and accessibility. Pragmatically, esketamine is chosen before ECT when both are indicated, but studies on ECT in ketamine non-responders are missing.
The international journal of neuropsychopharmacology
June 6, 2025
Benjamin Spurny-Dworak, Thomas Liebe, Samantha Graf et al.
2 citations
A single subanesthetic dose of intranasal esketamine rapidly increases the volume of specific right thalamic structures in healthy young adults. In a placebo-controlled crossover study with 26 participants, magnetic resonance imaging revealed significant enlargement of the right thalamus, the pulvinar anterior nucleus, and the right mediodorsal lateral parvocellular nucleus after esketamine administration. These structural changes occurred in thalamic regions that relay visual information to the cortex, suggesting that ketamine's effects on visual perception may arise from rapid adaptations in these brain areas. The findings highlight the thalamus as a key target for modeling schizophrenia symptoms and understanding ketamine's mechanism of action.
Therapeutic advances in psychopharmacology
January 1, 2026
Manfred Klöbl, Thomas Liebe, Gregor Dörl et al.
Ketamine reduces sexual arousal in a sex-specific manner, which may explain why it is used recreationally in chemsex settings despite dampening sexual experience. In two placebo-controlled crossover studies with 67 healthy volunteers, subacute S-ketamine lowered arousal to heterosexual stimuli in women and to lesbian stimuli in men, while decreasing sexual aversion to gay stimuli in both sexes. Late racemic ketamine reduced arousal to heterosexual stimuli in men but increased aversion to gay stimuli in women. Ketamine also modulated calcarine gyrus activity differently in men and women. These sex-dependent effects on brain activity and sexual response may relate to ketamine's known sex-specific influences on stress resilience and psychosis-like symptoms.